RecruitingAge-related condition
Real-world Patient Experiences With Inbrija® (INHALE-PD)
Real-world Patient Experiences With Inbrija® - Non-interventional Assessment of Inhaled Levodopa for the Management of OFF Episodes in Parkinson's Disease: a Mixed-methods Study
- Sponsor
- Merz Therapeutics GmbH (Industry)
- Enrolment
- 120 planned
- Conditions
- Parkinson Disease (PD); Parkinson's Disease; Off Episodes of Parkinson Disease
- Interventions
- Levodopa inhalation powder
- Ages
- adults, older adults
- Registry
- NCT07797790
Full record on ClinicalTrials.gov
From the registry
Parkinson's disease can cause OFF episodes, when medication effects wear off and symptoms return, affecting movement, daily activities, comfort, and wellbeing. This study aims to explore the experiences of people with Parkinson's disease who are prescribed Inbrija® as part of their usual care. Through a mixed-methods approach, the study will examine how OFF episodes affect patients, what influences their decision to use Inbrija®, and whether patient-reported outcomes related to symptoms, daily functioning, and quality of life change during the first 3 months of treatment. The study is planned to be conducted at approximately 7 sites in Austria, Germany, and Sweden and will enroll up to 120 participants receiving Inbrija® in routine clinical practice.
Primary outcomes
- Mean Within-Patient Change in PDQ-39 Mobility Domain Score From Baseline to Month 3
History
Study completion expected
Primary completion expected
Last registry update
Started
Registered